Clinical characteristics and outcomes of B-ALL with ZNF384 rearrangements: a retrospective analysis by the Ponte di Legno Childhood ALL Working Group
- PMID: 33692463
- PMCID: PMC8550960
- DOI: 10.1038/s41375-021-01199-0
Clinical characteristics and outcomes of B-ALL with ZNF384 rearrangements: a retrospective analysis by the Ponte di Legno Childhood ALL Working Group
Conflict of interest statement
C.G.M.: Research support from Loxo, Abbvie, Pfizer. Consulting and speaking fees from Amgen, Illumina. C-H Pui received consulting and speaker fees from Amgen, Erytech Phamra, and Servier. H.I. received a research grant from Servier.
Figures
References
-
- Hirabayashi S, Ohki K, Nakabayashi K, Ichikawa H, Momozawa Y, Okamura K, et al. ZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype. Haematologica. 2017;102:118–29. doi: 10.3324/haematol.2016.151035. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
